Medical Condition News

RSS

Trial compares two different lung volume reduction procedures for people with emphysema

The first randomized controlled trial to compare two different lung volume reduction procedures for people with emphysema has found that both lead to similar improvements in lung function, breathlessness and exercise capacity.

5 Sep 2022

Neurological manifestations associated with monkeypox infection

A new study presents current information regarding the neurological presentations and complications of monkeypox infection.

5 Sep 2022

Inhaled glucocorticoids linked to changes in brain matter

A recent BMJ Open study conducted a cross-sectional analysis to test the hypothesis that the usage of systemic and inhaled glucocorticoids was associated with alterations in grey matter volume (GMV) and white matter microstructure.

5 Sep 2022

Monkeypox infection causing acute myocarditis - case report

A recent case report published in the journal JACC Case Reports indicated that monkeypox infection might be associated with acute myocarditis or heart muscle inflammation.

5 Sep 2022

Combined stem cell and gene therapy shows promise to treat patients with ALS

Cedars-Sinai investigators have developed an investigational therapy using support cells and a protective protein that can be delivered past the blood-brain barrier.

5 Sep 2022

Studies show link between OSA and decline in mental processing powers, increased risk of blood clots, cancer

People who suffer from obstructive sleep apnea (OSA) are at an increased risk of cancer, according to a large study presented on Monday at the European Respiratory Society International Congress in Barcelona, Spain.

5 Sep 2022

High-quality human clinical trials needed to determine the benefits of CBD for heart disease patients

As cannabidiol (CBD) use rises, high quality randomized clinical trials are needed to determine if anti-inflammatory benefits of CBD for heart disease seen in preclinical data will work in a real-world setting, according to research presented at ACC Latin America 2022 Together with CardioAcademic.

5 Sep 2022

MOO can alleviate depression via increasing 5-HTP in the gut microbiota, study reveals

Announcing a new article publication from Acta Pharmaceutica Sinica B. Morinda officinalis oligosaccharides(MOO) is an oral drug approved in China for the treatment of depression in China.

5 Sep 2022

Targeting Gαq/11 may be an efficient therapeutic strategy against uveal melanoma

Announcing a new article publication from Acta Pharmaceutica Sinica B. Constitutively activated G proteins caused by specific mutations mediate the development of multiple malignancies.

5 Sep 2022

Recent advances in nano-based therapeutic strategies for the treatment of infectious lung diseases

Announcing a new publication for Acta Materia Medica journal. Infectious lung diseases are inflammatory diseases of the lungs caused by infectious agents such as bacteria, viruses or fungi.

5 Sep 2022

Bronchodilators do little to help people without COPD but have smoking-related respiratory symptoms

Researchers supported by the National Institutes of Health have found that dual bronchodilators - long-lasting inhalers that relax the airways and make it easier to breathe - do little to help people who do not have chronic obstructive pulmonary disease (COPD), but who do have respiratory symptoms and a history of smoking.

5 Sep 2022

Researchers secure $20.5 million NIH grant to beat Alzheimer's disease and related dementias

A team of researchers at the University of Kentucky's Sanders-Brown Center on Aging has been awarded a $20.5 million grant from the National Institute on Aging of the National Institutes of Health.

2 Sep 2022

Cooler ambient temperatures in the tropics increase risk of heart attacks

Scientists have long known that temperature changes impact the incidence of heart attacks. However, most of the research done so far has been in temperate climates, where temperatures range widely.

2 Sep 2022

Case study shows potential to develop myocarditis following monkeypox infection

A 31-year-old male with confirmed monkeypox infection developed acute myocarditis approximately one week following the onset of monkeypox symptoms, according to a case study published today in JACC: Case Reports.

2 Sep 2022

Clinical trial shows efficacy and safety of belimumab in East Asian adults with lupus nephritis

This prespecified subgroup analysis of East Asian adults who participated in a phase 3 clinical trial of belimumab added to standard therapy vs. placebo added to standard therapy for lupus nephritis shows earlier and more sustained improvement in kidney outcomes with the addition of belimumab.

2 Sep 2022

Circadian rhythm disruption is shared by a broad range of mental illnesses, study finds

Anxiety, autism, schizophrenia and Tourette syndrome each have their own distinguishing characteristics, but one factor bridging these and most other mental disorders is circadian rhythm disruption, according to a team of neuroscience, pharmaceutical sciences and computer science researchers at the University of California, Irvine.

2 Sep 2022

Depletion of reactive astrocytes regresses glioblastoma

A groundbreaking study at Tel Aviv University effectively eradicated glioblastoma, a highly lethal type of brain cancer. The researchers achieved the outcome using a method they developed based on their discovery of two critical mechanisms in the brain that support tumor growth and survival: one protects cancer cells from the immune system, while the other supplies the energy required for rapid tumor growth. The work found that both mechanisms are controlled by brain cells called astrocytes, and in their absence, the tumor cells die and are eliminated.

2 Sep 2022

Researchers develop novel therapeutic strategy to treat Huntington's disease

Through an international joint research effort involving ProQR Therapeutics of the Netherlands, Université Grenoble Alpes of France, and KTH Royal Institute of Technology of Sweden, Professor Ji-Soon Song's research team in the Department of Biological Sciences and KAIST Institute for BioCentury of KAIST, established a noble strategy to treat Huntington's disease. The new works showed that the protein converted from disease form to its disease-free form maintains its original function, providing new roadblocks to approach Huntington's disease.

2 Sep 2022

GnRH therapy could improve cognitive deficits in men with Down syndrome

Gonadotropin-releasing hormone (GnRH) therapy improves cognitive function in Down syndrome (DS) mouse models and male patients with DS, according to a new study.

1 Sep 2022

Researchers identify how some cancer cells cheat treatment-induced cell death

Scientists at St. Jude Children's Research Hospital have identified how some cancer cells cheat treatment-induced cell death.

1 Sep 2022

Medical Condition News

Trial compares two different lung volume reduction procedures for people with emphysema

Neurological manifestations associated with monkeypox infection

Inhaled glucocorticoids linked to changes in brain matter

Monkeypox infection causing acute myocarditis - case report

Combined stem cell and gene therapy shows promise to treat patients with ALS

Studies show link between OSA and decline in mental processing powers, increased risk of blood clots, cancer

High-quality human clinical trials needed to determine the benefits of CBD for heart disease patients

MOO can alleviate depression via increasing 5-HTP in the gut microbiota, study reveals

Targeting Gαq/11 may be an efficient therapeutic strategy against uveal melanoma

Recent advances in nano-based therapeutic strategies for the treatment of infectious lung diseases

Bronchodilators do little to help people without COPD but have smoking-related respiratory symptoms

Researchers secure $20.5 million NIH grant to beat Alzheimer's disease and related dementias

Cooler ambient temperatures in the tropics increase risk of heart attacks

Case study shows potential to develop myocarditis following monkeypox infection

Clinical trial shows efficacy and safety of belimumab in East Asian adults with lupus nephritis

Circadian rhythm disruption is shared by a broad range of mental illnesses, study finds

Depletion of reactive astrocytes regresses glioblastoma

Researchers develop novel therapeutic strategy to treat Huntington's disease

GnRH therapy could improve cognitive deficits in men with Down syndrome

Researchers identify how some cancer cells cheat treatment-induced cell death

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Latest News